Technical Assistance Report No. TA-78-33: William T. Burnett Company: Baltimore, Maryland
Public Domain
-
1978/11/01
File Language:
English
Details
-
Personal Author:
-
Corporate Authors:
-
Description:Urinary and neurological disorders among workers at the William T. Burnett Company (SIC-2824) in Baltimore, Maryland, were investigated from April 7 to May 5, 1978. The investigation was requested by the Assistant Secretary of Labor, OSHA, after workers reported various urinary and neurological symptoms. Medical questionnaires revealed widespread cases of urinary retention among workers. Skin problems and visual disorders were also prevalent among workers. Weakness and paresthesia were also reported by several workers, as were cases of sexual dysfunction. Environmental sampling revealed the presence of toluene-diisocyanate (584849) (TDI), N-ethylmorpholine (100743), dimethyl-piperazine (106581), formaldehyde (50000), propionaldehyde (123386), cyclopentanone (120923), methylene- chloride (75092), N-methyl-morpholine (109024), and acetone (67641). TDI concentrations ranged from 0.009 to 0.206 milligrams per cubic meter (mg/CuM), compared with the OSHA standard of 0.14mg/CuM. All other sampled substances were below their respective exposure criteria or were in trace amounts. The author concludes that the reports of employee urological and neurological disorders, and possibly the sexual dysfunctions, resulted from exposure to the recently introduced NIA-catalyst-ESN, a mixture of dimethylamino- propionitrile (1738256), and bis(2-(dimethylamino)ethyl)ether (3033623). Other health problems noted during the survey, including skin, eye, and respiratory symptoms may have resulted from other occupational exposures, but were not of primary consideration in the present survey. The author recommends strict personal hygiene and adherence to good work practices, development of a health and safety program, maintenance of toxicity data for all substances used, periodic medical monitoring of workers, and ventilation modifications to reduce employee exposures to chemicals.
-
Subjects:
-
Series:
-
Publisher:
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:57 pdf pages
-
Contributor:Flesch, Jerome P. ; Costello, Richard J. ; Price, James P. ; Love, John ; Thoburn, Theodore W. ; Allen, Elizabeth ; Wertheimer, Debra ; Burton, John ; Fine, Matthew ; Nissim, Jack ; Paxton, Gary ; Schafer, Edward ; Chatham, Frank ; Freedman, Franca ; Kent, Surry ; Reath, Geri ; Bietila, Susan ; Molinaro, John ; Loden, Vicki ; Milton, Donald ; Grote, Ardith A. ; Ball, Spencer ; Lebrizzi, Joe ; Perry, Carole ; Dorsey, Christine ; Delmage, Robert M. ; Sollers, Joseph ; Haden, Etta ; Wilson, Anthony ; Moreland, Rebecca ; Pestronk, Allan
-
NIOSHTIC Number:nn:00124522
-
NTIS Accession Number:PB82-196049
-
Citation:Cincinnati, Ohio: U.S. Department of Health, Education, and Welfare, Public Health Service, Centers for Disease Control, National Institute for Occupational Safety and Health, TA 78-33, 1978 November ; 1-57
-
CAS Registry Number:2,4-Toluene diisocyanate (CAS RN 584-84-9) ; N-Ethylmorpholine (CAS RN 100-74-3) ; 1,4-Dimethylpiperazine (CAS RN 106-58-1) ; Formaldehyde (CAS RN 50-00-0) ; Propionaldehyde (CAS RN 123-38-6) ; Cyclopentanone (CAS RN 120-92-3) ; Methylene chloride (CAS RN 75-09-2) ; 4-Methylmorpholine (CAS RN 109-02-4) ; Acetone (CAS RN 67-64-1) ; 3-(Dimethylamino)-propanenitrile (CAS RN 1738-25-6) ; Bis(2-dimethylaminoethyl) ether (CAS RN 3033-62-3)
-
Editor(s):
-
Federal Fiscal Year:1979
-
Peer Reviewed:False
-
NAICS and SIC Codes:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:7ab95d3cf58e71ba3151bde757faac2a1077459212bc633e003f5b2b723ff56d995714a05c88572e6320411f9c715a4e7da95e66c639fdb2f65cf25ac6043e19
-
Download URL:
-
File Type:
File Language:
English
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like